A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation

by Michele Maio, Michael Lahn, Anna Maria Di Giacomo, Alessia Covre, Luana Calabrò, Ramy Ibrahim, Bernard Fox, The Siena Think Tank
Published 2021-07-01

Immunotherapy of brain metastases: breaking a “dogma”

by Anna Maria Di Giacomo, Monica Valente, Alfonso Cerase, Maria Fortunata Lofiego, Francesca Piazzini, Luana Calabrò, Elisabetta Gambale, Alessia Covre, Michele Maio
Published 2019-10-01

KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma

by Inge Marie Svane, Razi Ghori, Anna Maria Di Giacomo, Henrik Schmidt, Eduard Gasal, Michal Lotem, Michele Del Vecchio, Pier Francesco Ferrucci, Rosalie Stephens, Mahmoud Abu-Amna, Scott J Diede, Elizabeth S Croydon
Published 2020-07-01

Immunomodulatory Properties of DNA Hypomethylating Agents: Selecting the Optimal Epigenetic Partner for Cancer Immunotherapy

by Carolina Fazio, Alessia Covre, Ornella Cutaia, Maria Fortunata Lofiego, Patrizia Tunici, Carla Chiarucci, Sara Cannito, Gianluca Giacobini, James N. Lowder, Roberta Ferraldeschi, Pietro Taverna, Anna Maria Di Giacomo, Sandra Coral, Michele Maio
Published 2018-12-01

Circulating Levels of PD-L1 in Mesothelioma Patients from the NIBIT-MESO-1 Study: Correlation with Survival

by Carla Chiarucci, Sara Cannito, Maria Grazia Daffinà, Giovanni Amato, Gianluca Giacobini, Ornella Cutaia, Maria Fortunata Lofiego, Carolina Fazio, Diana Giannarelli, Riccardo Danielli, Anna Maria Di Giacomo, Sandra Coral, Luana Calabrò, Michele Maio, Alessia Covre
Published 2020-02-01

Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients

by Cristina Maccalli, Diana Giannarelli, Carla Chiarucci, Ornella Cutaia, Gianluca Giacobini, Wouter Hendrickx, Giovanni Amato, Diego Annesi, Davide Bedognetti, Maresa Altomonte, Riccardo Danielli, Luana Calabrò, Anna Maria Di Giacomo, Francesco M. Marincola, Giorgio Parmiani, Michele Maio
Published 2017-07-01

The density and spatial tissue distribution of CD8+ and CD163+ immune cells predict response and outcome in melanoma patients receiving MAPK inhibitors

by Daniela Massi, Eliana Rulli, Mara Cossa, Barbara Valeri, Monica Rodolfo, Barbara Merelli, Francesco De Logu, Romina Nassini, Michele Del Vecchio, Lorenza Di Guardo, Roberta De Penni, Michele Guida, Vanna Chiarion Sileni, Anna Maria Di Giacomo, Marco Tucci, Marcella Occelli, Francesca Portelli, Viviana Vallacchi, Francesca Consoli, Pietro Quaglino, Paola Queirolo, Gianna Baroni, Fabrizio Carnevale-Schianca, Laura Cattaneo, Alessandro Minisini, Giuseppe Palmieri, Licia Rivoltini, Mario Mandalà, on behalf of the Italian Melanoma Intergroup
Published 2019-11-01